Favipiravir is a Broad Spectrum Antiviral Prescription Famous to Selectivity Block RNA-Dependent RNA Polymerase (RdRp) and SARS- COVID-19
INTRODUCTION Favipiravir is a customized pyrazine analog that was originally permitted for therapeutic use in resistant cases of influenza. The antiviral targets RNA-reliant RNA polymerase (RdRp) enzymes, which are essential for the record and copying of viral genomes [1]. Favipiravir control copying of influenza A and B, but the drug has shown assure in the treatment of …